Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000937887 | SCV001083681 | likely benign | Hypertrophic cardiomyopathy | 2024-11-04 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV001186706 | SCV001353260 | likely benign | Cardiomyopathy | 2018-11-21 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV000937887 | SCV004836593 | likely benign | Hypertrophic cardiomyopathy | 2023-11-28 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004639416 | SCV005144242 | likely benign | Cardiovascular phenotype | 2024-03-29 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Diagnostic Laboratory, |
RCV001529744 | SCV001743731 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001529744 | SCV001975084 | likely benign | not provided | no assertion criteria provided | clinical testing |